Kodiak Sciences (KOD) EBITDA (2017 - 2026)

Kodiak Sciences has reported EBITDA for 10 years, with the latest figure at -$59.8 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA fell 1.19% year-over-year to -$59.8 million; the trailing twelve-month figure through Mar 2026 stood at -$235.1 million (down 22.29% YoY), and the FY2025 full-year result was -$230.0 million, down 30.51% from the prior year.
• EBITDA for Q1 2026 stood at -$59.8 million, down from -$57.5 million in the prior quarter.
• The five-year high for EBITDA was -$43.0 million in Q1 2024, with the low at -$95.7 million in Q1 2022.
• Historically, EBITDA has averaged -$62.6 million across 5 years, with a median of -$59.5 million in 2023.
• Annual changes were most pronounced in 2022 — EBITDA sank 89.59% — and 2024, when it soared 43.67%.
• Kodiak Sciences' EBITDA stood at -$69.2 million in 2022, then climbed by 14.06% to -$59.5 million in 2023, then climbed by 25.89% to -$44.1 million in 2024, then plunged by 30.26% to -$57.5 million in 2025, then decreased by 4.05% to -$59.8 million in 2026.
• The last three EBITDA figures came in at -$59.8 million (Q1 2026), -$57.5 million (Q4 2025), and -$62.4 million (Q3 2025), per Business Quant data.